The last several months of order increases have prompted Advantis CEO, Darren Cherry, to arrange for a more efficient canning system for its Amster-Can line of business. “Our Oregon partner had to send the smaller machine back so we can instantly add to our capacity,” Cherry explained. “We recognize that to keep up with our current rate of growth, we must significantly add to our production capacity. We have been working with N2Pack to develop an entirely self-contained canning system. We’ll be able to just load product in a bin, press a button, and have finished, labeled Amster-Can products rolling off the assembly line in seconds. It will also have functionality for other product types to be filled within any size can. This system will enable us to deliver our large machine to a partner that is about to start ramping up to that level very quickly. Nitrogen canning is becoming the industry standard, and we are the industry leader” Cherry alluded to statements made early last year about one of their partners building a cannabis campus so that several organizations can efficiently manufacture and package their products there; that project was said to be complete sometime this year.
Cherry says that in addition to the news about the canning machine increase, he is excited to announce that Advantis and its potential sublingual strip partner are ready to ink a deal this week. “This can be a game changer, partnering with a top manufacturer in the industry,” Cherry shared. “Their marketing reach and marketplace knowledge are unmatched. It is up to us to execute.” Cherry related his excitement with the sublingual strips by pivoting to several agreements that are on deck. “We are negotiating packaging and marketing agreements with several well-known names in the industry. Extremely large volume. The sublingual deal will establish our footprint in the sublingual space much more quickly than it took us to get to this point of negotiating with the largest of suppliers. We have a great name now, and even greater partners to work with.” Cherry concluded by saying that the company feels like it is turning a corner, and the marketplace is organically fueling its accelerating growth rate.
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.